Login to Your Account



Regulatory NEWS
The Centers for Medicare & Medicaid Services (CMS) Tuesday launched its official Open Payments website, an online database consolidating public information on payments made by drug- and devicemakers to doctors and medical schools.
Two key events that will shape the future of medicines regulation in Europe are taking place on Thursday. The European Parliament will scrutinize a controversial proposal from Jean Claude Juncker to transfer oversight of the EMA back to the EU's Directorate General. On the same day, the EMA is due to finalize its policy on clinical trial data transparency.
Late Friday Atlanta-based Alimera Sciences Inc. received the green light from the FDA for its Iluvien implant, indicated for diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.
More Regulatory Headlines

Cast Your Vote

Has biotech’s bubble burst?: